Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers
Status:
Completed
Trial end date:
2020-01-29
Target enrollment:
Participant gender:
Summary
The purpose of this research was to investigate whether Furosemide 40 mg tablet manufactured
by PT. Kimia Farma Tbk was bioequivalent to its reference drug and Lasix® 40 mg Tablet
manufactured by PT. Aventis Pharma, Indonesia.